Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Non Myeloablative Allogeneic Stem Cell Transplantation as Adjuvant Treatment in Patients With Pancreatic Adenocarcinoma

NCT02207985 is registered in ClinicalTrials.gov with Karolinska Institutet as lead sponsor.

NCT NCT02207985
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02207985 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Non Myeloablative Allogeneic Stem Cell Transplantation as Adjuvant Treatment in Patients With Pancreatic Adenocarcinoma
Lead sponsor
Karolinska Institutet
Phase
Phase 1/2
Overall status
Terminated
Start date
January 31, 2007
Completion date
June 1, 2017
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic adenocarcinoma